Efficacy and safety of atrial fibrillation ablation in patients with aged 80 years or older

Atrial fibrillation (AF) is the most common cardiac arrhythmia observed in the elderly. Its prevalence rises with age, particularly in individuals over 80 years old. While catheter ablation has emerged as a first line therapy for the patients with symptomatic AF, evidence on its application in elder...

Full description

Saved in:
Bibliographic Details
Published in:Heart and vessels 2024-09
Main Authors: Yodogawa, Kenji, Iwasaki, Yu-Ki, Ito, Nobuaki, Arai, Toshiki, Hachisuka, Masato, Fujimoto, Yuhi, Hagiwara, Kanako, Murata, Hiroshige, Aizawa, Yoshiyasu, Shimizu, Wataru, Asai, Kuniya
Format: Article
Language:English
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c184t-d9aba04fdf2f9456d4d7c1f1dd1a39267c7c6ccdc08ebf7340c8996c4b16aab93
container_end_page
container_issue
container_start_page
container_title Heart and vessels
container_volume
creator Yodogawa, Kenji
Iwasaki, Yu-Ki
Ito, Nobuaki
Arai, Toshiki
Hachisuka, Masato
Fujimoto, Yuhi
Hagiwara, Kanako
Murata, Hiroshige
Aizawa, Yoshiyasu
Shimizu, Wataru
Asai, Kuniya
description Atrial fibrillation (AF) is the most common cardiac arrhythmia observed in the elderly. Its prevalence rises with age, particularly in individuals over 80 years old. While catheter ablation has emerged as a first line therapy for the patients with symptomatic AF, evidence on its application in elderly patients remains controversial. This study aimed to assess safety and efficacy outcomes of AF ablation in patients aged ≥ 80 years. Consecutive 1327 patients who underwent a first pulmonary vein isolation (PVI) for AF were retrospectively analyzed. Patients aged ≥ 80 years (elderly group, n = 107) were compared with patients aged 
doi_str_mv 10.1007/s00380-024-02458-7
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3102881381</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3102881381</sourcerecordid><originalsourceid>FETCH-LOGICAL-c184t-d9aba04fdf2f9456d4d7c1f1dd1a39267c7c6ccdc08ebf7340c8996c4b16aab93</originalsourceid><addsrcrecordid>eNo9kEtPwzAQhC0EoqXwBzggH7kE1nYS20dUlYdUiQucOFgbP8AoTYqdCvXfk9KCtKudw85o9BFyyeCGAcjbDCAUFMDL3VaqkEdkympWFbyS4phMQTMolOByQs5y_gRglWb6lEyE5pXmXE_J2yKEaNFuKXaOZgx-2NI-UBxSxJaG2KTYtjjEvqPYHETs6HpUvhsy_Y7DB8V376gCuvWYMu0T7Vvn0zk5Cdhmf3G4M_J6v3iZPxbL54en-d2ysEyVQ-E0NghlcIEHXVa1K520LDDnGI5Fa2mlra11FpRvghQlWKV1bcuG1YiNFjNyvc9dp_5r4_NgVjFbP9bufL_JRjDgSjExzozw_atNfc7JB7NOcYVpaxiYHVSzh2pGoOYXqpGj6eqQv2lW3v1b_iiKH6PLcxc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3102881381</pqid></control><display><type>article</type><title>Efficacy and safety of atrial fibrillation ablation in patients with aged 80 years or older</title><source>Springer Link</source><creator>Yodogawa, Kenji ; Iwasaki, Yu-Ki ; Ito, Nobuaki ; Arai, Toshiki ; Hachisuka, Masato ; Fujimoto, Yuhi ; Hagiwara, Kanako ; Murata, Hiroshige ; Aizawa, Yoshiyasu ; Shimizu, Wataru ; Asai, Kuniya</creator><creatorcontrib>Yodogawa, Kenji ; Iwasaki, Yu-Ki ; Ito, Nobuaki ; Arai, Toshiki ; Hachisuka, Masato ; Fujimoto, Yuhi ; Hagiwara, Kanako ; Murata, Hiroshige ; Aizawa, Yoshiyasu ; Shimizu, Wataru ; Asai, Kuniya</creatorcontrib><description>Atrial fibrillation (AF) is the most common cardiac arrhythmia observed in the elderly. Its prevalence rises with age, particularly in individuals over 80 years old. While catheter ablation has emerged as a first line therapy for the patients with symptomatic AF, evidence on its application in elderly patients remains controversial. This study aimed to assess safety and efficacy outcomes of AF ablation in patients aged ≥ 80 years. Consecutive 1327 patients who underwent a first pulmonary vein isolation (PVI) for AF were retrospectively analyzed. Patients aged ≥ 80 years (elderly group, n = 107) were compared with patients aged &lt; 80 years (younger group, n = 1220). At 1-year follow-up, there was no significant difference in AF free rate between the elderly and the younger group (72.0% vs. 73.9%, P = 0.786). Regarding major complications, the elderly patients had a greater incidence of periprocedural stroke (1.9% vs. 0.1%, P = 0.018). The rates of cardiac tamponade, phrenic palsy, and vascular complications were not significantly different between the 2 groups. PVI for AF is effective in patients aged ≥ 80 years with a similar success rate, but periprocedural stoke risk was higher compared to the younger population.</description><identifier>ISSN: 0910-8327</identifier><identifier>ISSN: 1615-2573</identifier><identifier>EISSN: 1615-2573</identifier><identifier>DOI: 10.1007/s00380-024-02458-7</identifier><identifier>PMID: 39259229</identifier><language>eng</language><publisher>Japan</publisher><ispartof>Heart and vessels, 2024-09</ispartof><rights>2024. Springer Nature Japan KK, part of Springer Nature.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c184t-d9aba04fdf2f9456d4d7c1f1dd1a39267c7c6ccdc08ebf7340c8996c4b16aab93</cites><orcidid>0000-0001-9978-7402</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39259229$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yodogawa, Kenji</creatorcontrib><creatorcontrib>Iwasaki, Yu-Ki</creatorcontrib><creatorcontrib>Ito, Nobuaki</creatorcontrib><creatorcontrib>Arai, Toshiki</creatorcontrib><creatorcontrib>Hachisuka, Masato</creatorcontrib><creatorcontrib>Fujimoto, Yuhi</creatorcontrib><creatorcontrib>Hagiwara, Kanako</creatorcontrib><creatorcontrib>Murata, Hiroshige</creatorcontrib><creatorcontrib>Aizawa, Yoshiyasu</creatorcontrib><creatorcontrib>Shimizu, Wataru</creatorcontrib><creatorcontrib>Asai, Kuniya</creatorcontrib><title>Efficacy and safety of atrial fibrillation ablation in patients with aged 80 years or older</title><title>Heart and vessels</title><addtitle>Heart Vessels</addtitle><description>Atrial fibrillation (AF) is the most common cardiac arrhythmia observed in the elderly. Its prevalence rises with age, particularly in individuals over 80 years old. While catheter ablation has emerged as a first line therapy for the patients with symptomatic AF, evidence on its application in elderly patients remains controversial. This study aimed to assess safety and efficacy outcomes of AF ablation in patients aged ≥ 80 years. Consecutive 1327 patients who underwent a first pulmonary vein isolation (PVI) for AF were retrospectively analyzed. Patients aged ≥ 80 years (elderly group, n = 107) were compared with patients aged &lt; 80 years (younger group, n = 1220). At 1-year follow-up, there was no significant difference in AF free rate between the elderly and the younger group (72.0% vs. 73.9%, P = 0.786). Regarding major complications, the elderly patients had a greater incidence of periprocedural stroke (1.9% vs. 0.1%, P = 0.018). The rates of cardiac tamponade, phrenic palsy, and vascular complications were not significantly different between the 2 groups. PVI for AF is effective in patients aged ≥ 80 years with a similar success rate, but periprocedural stoke risk was higher compared to the younger population.</description><issn>0910-8327</issn><issn>1615-2573</issn><issn>1615-2573</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNo9kEtPwzAQhC0EoqXwBzggH7kE1nYS20dUlYdUiQucOFgbP8AoTYqdCvXfk9KCtKudw85o9BFyyeCGAcjbDCAUFMDL3VaqkEdkympWFbyS4phMQTMolOByQs5y_gRglWb6lEyE5pXmXE_J2yKEaNFuKXaOZgx-2NI-UBxSxJaG2KTYtjjEvqPYHETs6HpUvhsy_Y7DB8V376gCuvWYMu0T7Vvn0zk5Cdhmf3G4M_J6v3iZPxbL54en-d2ysEyVQ-E0NghlcIEHXVa1K520LDDnGI5Fa2mlra11FpRvghQlWKV1bcuG1YiNFjNyvc9dp_5r4_NgVjFbP9bufL_JRjDgSjExzozw_atNfc7JB7NOcYVpaxiYHVSzh2pGoOYXqpGj6eqQv2lW3v1b_iiKH6PLcxc</recordid><startdate>20240911</startdate><enddate>20240911</enddate><creator>Yodogawa, Kenji</creator><creator>Iwasaki, Yu-Ki</creator><creator>Ito, Nobuaki</creator><creator>Arai, Toshiki</creator><creator>Hachisuka, Masato</creator><creator>Fujimoto, Yuhi</creator><creator>Hagiwara, Kanako</creator><creator>Murata, Hiroshige</creator><creator>Aizawa, Yoshiyasu</creator><creator>Shimizu, Wataru</creator><creator>Asai, Kuniya</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-9978-7402</orcidid></search><sort><creationdate>20240911</creationdate><title>Efficacy and safety of atrial fibrillation ablation in patients with aged 80 years or older</title><author>Yodogawa, Kenji ; Iwasaki, Yu-Ki ; Ito, Nobuaki ; Arai, Toshiki ; Hachisuka, Masato ; Fujimoto, Yuhi ; Hagiwara, Kanako ; Murata, Hiroshige ; Aizawa, Yoshiyasu ; Shimizu, Wataru ; Asai, Kuniya</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c184t-d9aba04fdf2f9456d4d7c1f1dd1a39267c7c6ccdc08ebf7340c8996c4b16aab93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yodogawa, Kenji</creatorcontrib><creatorcontrib>Iwasaki, Yu-Ki</creatorcontrib><creatorcontrib>Ito, Nobuaki</creatorcontrib><creatorcontrib>Arai, Toshiki</creatorcontrib><creatorcontrib>Hachisuka, Masato</creatorcontrib><creatorcontrib>Fujimoto, Yuhi</creatorcontrib><creatorcontrib>Hagiwara, Kanako</creatorcontrib><creatorcontrib>Murata, Hiroshige</creatorcontrib><creatorcontrib>Aizawa, Yoshiyasu</creatorcontrib><creatorcontrib>Shimizu, Wataru</creatorcontrib><creatorcontrib>Asai, Kuniya</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Heart and vessels</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yodogawa, Kenji</au><au>Iwasaki, Yu-Ki</au><au>Ito, Nobuaki</au><au>Arai, Toshiki</au><au>Hachisuka, Masato</au><au>Fujimoto, Yuhi</au><au>Hagiwara, Kanako</au><au>Murata, Hiroshige</au><au>Aizawa, Yoshiyasu</au><au>Shimizu, Wataru</au><au>Asai, Kuniya</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Efficacy and safety of atrial fibrillation ablation in patients with aged 80 years or older</atitle><jtitle>Heart and vessels</jtitle><addtitle>Heart Vessels</addtitle><date>2024-09-11</date><risdate>2024</risdate><issn>0910-8327</issn><issn>1615-2573</issn><eissn>1615-2573</eissn><abstract>Atrial fibrillation (AF) is the most common cardiac arrhythmia observed in the elderly. Its prevalence rises with age, particularly in individuals over 80 years old. While catheter ablation has emerged as a first line therapy for the patients with symptomatic AF, evidence on its application in elderly patients remains controversial. This study aimed to assess safety and efficacy outcomes of AF ablation in patients aged ≥ 80 years. Consecutive 1327 patients who underwent a first pulmonary vein isolation (PVI) for AF were retrospectively analyzed. Patients aged ≥ 80 years (elderly group, n = 107) were compared with patients aged &lt; 80 years (younger group, n = 1220). At 1-year follow-up, there was no significant difference in AF free rate between the elderly and the younger group (72.0% vs. 73.9%, P = 0.786). Regarding major complications, the elderly patients had a greater incidence of periprocedural stroke (1.9% vs. 0.1%, P = 0.018). The rates of cardiac tamponade, phrenic palsy, and vascular complications were not significantly different between the 2 groups. PVI for AF is effective in patients aged ≥ 80 years with a similar success rate, but periprocedural stoke risk was higher compared to the younger population.</abstract><cop>Japan</cop><pmid>39259229</pmid><doi>10.1007/s00380-024-02458-7</doi><orcidid>https://orcid.org/0000-0001-9978-7402</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0910-8327
ispartof Heart and vessels, 2024-09
issn 0910-8327
1615-2573
1615-2573
language eng
recordid cdi_proquest_miscellaneous_3102881381
source Springer Link
title Efficacy and safety of atrial fibrillation ablation in patients with aged 80 years or older
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T20%3A53%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Efficacy%20and%20safety%20of%20atrial%20fibrillation%20ablation%20in%20patients%20with%20aged%2080%20years%20or%20older&rft.jtitle=Heart%20and%20vessels&rft.au=Yodogawa,%20Kenji&rft.date=2024-09-11&rft.issn=0910-8327&rft.eissn=1615-2573&rft_id=info:doi/10.1007/s00380-024-02458-7&rft_dat=%3Cproquest_cross%3E3102881381%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c184t-d9aba04fdf2f9456d4d7c1f1dd1a39267c7c6ccdc08ebf7340c8996c4b16aab93%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3102881381&rft_id=info:pmid/39259229&rfr_iscdi=true